New vaccines for the prevention of pneumococcal infections

H Käyhty1, J Eskola

  • 1Department of Vaccines, National Public Health Institute, Helsinki, Finland. helena.kayhty@ktl.fi

Insights

Vaccination against Streptococcus pneumoniae is crucial due to rising antibiotic resistance. New conjugate vaccines show promise in improving immunogenicity and efficacy against pneumococcal infections, especially in vulnerable populations.

Area of Science:

  • Microbiology
  • Immunology
  • Vaccinology

Background:

  • Streptococcus pneumoniae causes severe infections like pneumonia and meningitis.
  • Emerging antibiotic-resistant strains necessitate improved vaccination strategies.
  • Current vaccines are ineffective in young children and immunocompromised individuals.

Purpose of the Study:

  • To address the urgent need for effective vaccines against Streptococcus pneumoniae.
  • To evaluate the potential of novel pneumococcal vaccine candidates.
  • To investigate the efficacy of pneumococcal conjugate vaccines.

Main Methods:

  • Clinical trials of first-generation pneumococcal conjugate vaccines.
  • Covalent coupling of pneumococcal capsular polysaccharides to protein carriers.
  • Studying the protective efficacy against pneumococcal carriage and invasive infections.

Main Results:

  • Pneumococcal conjugate vaccines improve polysaccharide immunogenicity.
  • Efficacy against carriage, acute otitis media, and invasive infections is under investigation.
  • Development of more effective vaccines against Streptococcus pneumoniae is ongoing.

Conclusions:

  • Pneumococcal conjugate vaccines represent a significant advancement in preventing pneumococcal diseases.
  • Further research is essential to optimize vaccine efficacy and broaden protection.
  • Vaccination remains a key strategy to combat pneumococcal infections and antibiotic resistance.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...